doi.org/10.1038/s41375-021-01125-4

Other

Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML

Mikkael A. Sekeres

,

Justin M. Watts

,

..., Lionel Adès

Volume: 35, Issue: 7, Pages: 2119 - 2124

Published: Jan 22, 2021

Paper Fields

Paper Details

Title

Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML

DOI

doi.org/10.1038/s41375-021-01125-4

Published Date

Jan 22, 2021

Journal

Volume

35

Issue

7

Pages

2119 - 2124

Notes

History